After 62 years of regulating immunity, dexamethasone meets COVID-19.

Subjects

Subjects :

Alarmins antagonists & inhibitors
Alarmins genetics
Alarmins immunology
Betacoronavirus immunology
COVID-19
Coronavirus Infections immunology
Coronavirus Infections pathology
Coronavirus Infections virology
Cytokine Release Syndrome immunology
Cytokine Release Syndrome pathology
Cytokine Release Syndrome virology
Drug Administration Schedule
Humans
Immunity, Innate drug effects
Pandemics
Pneumonia, Viral immunology
Pneumonia, Viral pathology
Pneumonia, Viral virology
Randomized Controlled Trials as Topic
Receptors, Glucocorticoid antagonists & inhibitors
Receptors, Glucocorticoid genetics
Receptors, Glucocorticoid immunology
SARS-CoV-2
Severity of Illness Index
Time Factors
Anti-Inflammatory Agents therapeutic use
Betacoronavirus pathogenicity
Coronavirus Infections drug therapy
Cytokine Release Syndrome prevention & control
Dexamethasone therapeutic use
Immunosuppressive Agents therapeutic use
Pneumonia, Viral drug therapy

Details

Language :

English

ISSN :

1474-1741

Volume :

20

Issue :

10

Database :

MEDLINE

Journal :

Nature reviews. Immunology

Publication Type :

Academic Journal

Accession number :

32778829

Full Text :

https://doi.org/10.1038/s41577-020-00421-x